The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Propagation of Tau Misfolding from the Outside to the Inside of a Cell
Open accessAbstract
Tauopathies are neurodegenerative diseases characterized by aggregation of the microtubule-associated protein Tau in neurons and glia. Although Tau is normally considered an intracellular protein, Tau aggregates are observed in the extracellular space, and Tau peptide is readily detected in the cerebrospinal fluid of patients. Tau aggregation occurs in many diseases, including Alzheimer disease and frontotemporal dementia. Tau pathology begins in discrete, disease-specific regions but eventually involves much larger areas of the brain. It is unknown how this propagation of Tau misfolding occurs. We hypothesize that extracellular Tau aggregates can transmit a misfolded state from the outside to the inside of a cell, similar to prions. Here we show that extracellular Tau aggregates, but not monomer, are taken up by cultured cells. Internalized Tau aggregates displace tubulin, co-localize with dextran, a marker of fluid-phase endocytosis, and induce fibrillization of intracellular full-length Tau. These intracellular fibrils are competent to seed fibril formation of recombinant Tau monomer in vitro. Finally, we observed that newly aggregated intracellular Tau transfers between co-cultured cells. Our data indicate that Tau aggregates can propagate a fibrillar, misfolded state from the outside to the inside of a cell. This may have important implications for understanding how protein misfolding spreads through the brains of tauopathy patients, and it is potentially relevant to myriad neurodegenerative diseases associated with protein misfolding.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Pathogenic forms of tau spread toxicity between cells through a prion-like mechanism involving seeded conformational change (Colin et al. 2020, Frost et al. 2009).”
From The Role of Retrotransposons and Endogenous Retroviruses in Age-Dependent Neurodegenerative Disorders (2024) · cites this paper as Frost et al. 2009
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Several lines of evidence indicate tau propagates pathology among neurons.”
From Spontaneous pathology in PS19 tauopathy mice progresses via brain networks (2025) · cites this paper as Frost et al., 2009
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Proteopathic tau seeds are capable of entering a cell and promoting aggregation in a prion-like manner (Clavaguera et al., 2009; Frost et al., 2009).”
From Network analysis identifies strain-dependent response to tau and tau seeding-associated genes (2023) · cites this paper as Frost et al., 2009
The cited source says what the claim attributes to it.
In the citing paper
“Tau assemblies enter cells to trigger intracellular aggregation (Frost et al., 2009; Holmes et al., 2014)”
From Spontaneous pathology in PS19 tauopathy mice progresses via brain networks (2025) · cites this paper as Frost et al., 2009
In the citing paper
“The aggregation of tau impairs the axons, leading to neurodegeneration [23].”
From The Multifaceted Role of Neuroprotective Plants in Alzheimer’s Disease Treatment (2022) · cites this paper as [23]
In the citing paper
“The current clinical trial literature is compatible with the idea that AβP-related substances kindle a self-propagating process related to neocortical NFTs, as has been hypothesized (266-269).”
From Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature (2012) · cites this paper as [267]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Inflammation and Alzheimer’s disease
Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514
Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17
Hutton, M., Lendon, C. L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., Pickering-Brown, S., Chakraverty, S., Isaacs, A., Grover, A., et al. (1998) · Nature · doi:10.1038/31508 · Cited by 3,498
A protein factor essential for microtubule assembly
Weingarten, M. D., Lockwood, A. H., Hwo, S. Y., & Kirschner, M. W. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.5.1858 · Cited by 3,089
Lee, V. M.-Y., Goedert, M., & Trojanowski, J. Q. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.1121 · Cited by 2,480
Frequency of Stages of Alzheimer-Related Lesions in Different Age Categories
Braak, H., & Braak, E. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)00056-0 · Cited by 1,656
Mutation in the tau gene in familial multiple system tauopathy with presenile dementia
Spillantini, M. G., Murrell, J. R., Goedert, M., Farlow, M. R., Klug, A., & Ghetti, B. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.13.7737 · Cited by 1,474
Arnold, S. E., Hyman, B. T., Flory, J., Damasio, A. R., & Van Hoesen, G. W. (1991) · Cerebral Cortex · doi:10.1093/cercor/1.1.103 · Cited by 1,380
Tau is a candidate gene for chromosome 17 frontotemporal dementia
Poorkaj, P., Bird, T. D., Wijsman, E., Nemens, E., Garruto, R. M., Anderson, L., Andreadis, A., Wiederholt, W. C., Raskind, M., & Schellenberg, G. D. (1998) · Annals of Neurology · doi:10.1002/ana.410430617 · Cited by 1,374
Research works printed but not linked: 2
- Delacourte, 2005, Polish Acad. Sci., 43, 244
- DePace, 2002, Nat. Struct. Biol., 9, 389
Cited by
Sorted by citations
Items 601–700 of 1,001
Tau proteinopathies and the prion concept
(2020) · Progress in Molecular Biology and Translational Science · doi:10.1016/bs.pmbts.2020.08.003 · Cited by 38
Overlaps and divergences between tauopathies and synucleinopathies: a duet of neurodegeneration
Li, W., & Li, J. (2024) · Translational Neurodegeneration · doi:10.1186/s40035-024-00407-y · Cited by 37
Gu, J., & Sigurdsson, E. M. (2011) · Journal of Molecular Neuroscience · doi:10.1007/s12031-011-9576-5 · Cited by 36
Internalization and Axonal Transport of the HIV Glycoprotein gp120
Berth, S. H., Caicedo, H. H., Sarma, T., Morfini, G. A., & Brady, S. T. (2015) · ASN NEURO · doi:10.1177/1759091414568186 · Cited by 34
Shamir, D. B., Rosenqvist, N., Rasool, S., Pedersen, J. T., & Sigurdsson, E. M. (2016) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2016.01.013 · Cited by 34
Tau Seeding Mouse Models with Patient Brain-Derived Aggregates
Robert, A., Schöll, M., & Vogels, T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22116132 · Cited by 37
Multifaceted Alzheimer’s Disease: Building a Roadmap for Advancement of Novel Therapies
Kaur, D., Behl, T., Sehgal, A., Singh, S., Sharma, N., & BUNGAU, S. G. (2021) · Neurochemical Research · doi:10.1007/s11064-021-03415-w · Cited by 34
Tau Protein and Frontotemporal Dementias
Goedert, M., Spillantini, M. G., Falcon, B., Zhang, W., Newell, K. L., Hasegawa, M., Scheres, S. H. W., & Ghetti, B. F. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-51140-1_12 · Cited by 37
Amyotrophic lateral sclerosis: Is the spinal fluid pathway involved in seeding and spread?
Smith, R. A., Myers, K. J., Ravits, J., & Bowser, R. P. (2015) · Medical Hypotheses · doi:10.1016/j.mehy.2015.07.014 · Cited by 34
Pharmacological Modulators of Tau Aggregation and Spreading
Dominguez‐Meijide, A., Vasili, E., & Outeiro, T. F. (2020) · Brain Sciences · doi:10.3390/brainsci10110858 · Cited by 36
Choi, C., Gwin, M. S., Voth, S. B., Kolb, C., Zhou, C., Nelson, A. R., Deweever, A., Koloteva, A., Annamdevula, N. S., Murphy, J. M., et al. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101482 · Cited by 33
Prion-like Mechanisms in Alzheimer's Disease
Yin, R., Tan, L., Jiang, T., & Yu, J. (2014) · Current Alzheimer Research · doi:10.2174/156720501108140910121425 · Cited by 33
Bakota, L., Ussif, A. M., Jeserich, G., & Brandt, R. (2017) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2017.03.003 · Cited by 33
Prion-like properties of Tau assemblies
Clavaguera, F., Duyckaerts, C. J., & Haı̈k, S. (2020) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2019.11.022 · Cited by 32
Inter‐endothelial Transport of Microvectors using Cellular Shuttles and Tunneling Nanotubes
Ferrati, S., Shamsudeen, S., Summers, H. D., Rees, P. C. T., Abbey, J. V. A., Schmulen, J., Liu, X., Wong, S. T. C., Bean, A. J., Mauro Ferrari, B., et al. (2012) · Small · doi:10.1002/smll.201200472 · Cited by 32
Preparation of stable tau oligomers for cellular and biochemical studies
Karikari, T. K., Nagel, D. A., Grainger, A. I., Clarke-Bland, C., Hill, E. J., & Moffat, K. G. (2018) · Analytical Biochemistry · doi:10.1016/j.ab.2018.10.013 · Cited by 33
Klupp, E., Förster, S., Grimmer, T., Tahmasian, M., Yakushev, I. Y., Sorg, C., Yousefi, B. H., & Drzezga, A. E. (2014) · Brain Connectivity · doi:10.1089/brain.2013.0212 · Cited by 31
Pace, M. C., Xu, G. M., Fromholt, S., Howard, J. C., Crosby, K. W., Giasson, B. I., Lewis, J. M., & Borchelt, D. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1895-y · Cited by 31
A synthetic heparinoid blocks Tau aggregate cell uptake and amplification
Stopschinski, B. E., Thomas, T. L., Nadji, S., Darvish, E., Fan, L., Holmes, B. B., Modi, A. R., Finnell, J. G., Kashmer, O. M., Estill, S. J., et al. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.010353 · Cited by 31
Self-citationShin, S., Kim, D., Song, J. Y., Jeong, H., Hyeon, S. J., Kowall, N. W., Ryu, H., Pae, A. N., Lim, S., & Kim, Y. K. (2020) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2020.101782 · Cited by 29
Medina, M., & Ávila, J. (2013) · Expert Review of Neurotherapeutics · doi:10.1586/ern.13.39 · Cited by 33
Pająk, B., Kania, E., & Orzechowski, A. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/1805304 · Cited by 31
Transcellular Spreading of Tau in Tauopathies
Demaegd, K. C., Schymkowitz, J. W. H., & Rousseau, F. (2018) · ChemBioChem · doi:10.1002/cbic.201800288 · Cited by 32
Therapeutic Strategies for Restoring Tau HomeostasisPreprint
Young, Z. T., Mok, S., & Gestwicki, J. E. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a024612 · Cited by 31
Somatostatin and the pathophysiology of Alzheimer’s disease
Almeida, V. N. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102270 · Cited by 31
Ye, J., Zhong, S., Wan, H., Guo, X., Yao, X., Liu, Q., Chen, L., Wang, J., & Xiao, S. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00796-2 · Cited by 31
Propagation of the Prion Phenomenon: Beyond the Seeding Principle
Münch, C., & Bertolotti, A. (2012) · Journal of Molecular Biology · doi:10.1016/j.jmb.2011.12.061 · Cited by 31
Shively, S. B., Priemer, D. S., Stein, M. B., & Perl, D. P. (2021) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2021.04.003 · Cited by 32
Kang, S., Han, Z. Z., Daude, N., McNamara, E., Wohlgemuth, S. L., Molina‐Porcel, L., Safar, J., Mok, S., & Westaway, D. A. (2021) · BMC Biology · doi:10.1186/s12915-021-01132-y · Cited by 31
Alzheimer's disease and synapse Loss: What can we learn from induced pluripotent stem Cells?
Rodríguez-Jiménez, F. J., Ureña‐Peralta, J. R., Jendelová, P., & Erceg, S. (2023) · Journal of Advanced Research · doi:10.1016/j.jare.2023.01.006 · Cited by 33
Tau phosphorylation in hippocampus results in toxic gain-of-function
Ávila, J., de Barreda, E. G., Engel, T., Lucas, J. J., & Hernández, F. (2010) · Biochemical Society Transactions · doi:10.1042/bst0380977 · Cited by 33
Karikari, T. K., Turner, A., Stass, R., Lee, L. C. Y., Wilson, B., Nagel, D. A., Hill, E. J., & Moffat, K. G. (2016) · Protein Expression and Purification · doi:10.1016/j.pep.2016.09.009 · Cited by 31
The Multifaceted Role of Neuroprotective Plants in Alzheimer’s Disease Treatment
Zieneldien, T., Kim, J., & Cao, C. (2022) · Geriatrics · doi:10.3390/geriatrics7020024 · Cited by 29
“The aggregation of tau impairs the axons, leading to neurodegeneration [23].”
BackgroundAlzheimer’s disease seeded tau forms paired helical filaments yet lacks seeding potential
Duan, P., Dregni, A. J., Xu, H. W., Changolkar, L. N., Lee, V. M. ‐., Lee, E. B., & Hong, M. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.107730 · Cited by 36
In Vivo Spreading of Tau Pathology
Soto, C. A. (2012) · Neuron · doi:10.1016/j.neuron.2012.02.006 · Cited by 30
Martínez-Valbuena, I., Valenti‐Azcarate, R., Amat, I., Marcilla, I., Martí‐Andrés, G., Caballero, M. C., Riverol, M., Tuñon, M.-T., Fraser, P. E., & Luquín, M. R. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01171-0 · Cited by 30
The dual fates of exogenous tau seeds: Lysosomal clearance versus cytoplasmic amplification
Kolay, S., Vega, A. R., Dodd, D. A., Perez, V. A., Kashmer, O. M., White, C. L., & Diamond, M. I. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.102014 · Cited by 29
Self-citationInvolvement of endoplasmic reticulum stress in tauopathy
Sakagami, Y., Kudo, T., Tanimukai, H., Kanayama, D., Omi, T., Horiguchi, K., Okochi, M., Imaizumi, K., & Takeda, M. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.12.007 · Cited by 29
Probing Conformational Dynamics of Tau Protein by Hydrogen/Deuterium Exchange Mass Spectrometry
Huang, R. Y. ‐., Iacob, R. E., Sankaranarayanan, S., Yang, L., Ahlijanian, M. K., Tao, L., Tymiak, A. A., & Chen, G. (2017) · Journal of the American Society for Mass Spectrometry · doi:10.1007/s13361-017-1815-8 · Cited by 30
Zhang, L., & Wei, X. (2022) · Journal of Neuroscience · doi:10.1523/jneurosci.0059-22.2022 · Cited by 36
Meisl, G., Knowles, T. P. J., & Klenerman, D. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.909861 · Cited by 28
Martin, S. P., & Leeman-Markowski, B. A. (2024) · Frontiers in Neurology · doi:10.3389/fneur.2023.1287545 · Cited by 30
Protein aggregation and prionopathies
Renner, M. L., & Melki, R. (2014) · Pathologie Biologie · doi:10.1016/j.patbio.2014.01.003 · Cited by 31
Primio, C. D., Quercioli, V., Siano, G., Rovere, M., Kováčech, B., Novák, M., & Cattaneo, A. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00210 · Cited by 30
Inhibition of CK2 mitigates Alzheimer’s tau pathology by preventing NR2B synaptic mislocalization
Marshall, C. A., McBride, J. D., Changolkar, L. N., Riddle, D. M., Trojanowski, J. Q., & Lee, V. M. ‐. (2022) · Acta Neuropathologica Communications · doi:10.1186/s40478-022-01331-w · Cited by 28
Sattarov, R., Havers, M., Orbjörn, C., Stomrud, E., Janelidze, S., Laurell, T., & Mattsson, N. (2024) · Scientific Reports · doi:10.1038/s41598-024-75406-0 · Cited by 29
A Rapid Gene Delivery-Based Mouse Model for Early-Stage Alzheimer Disease-Type Tauopathy
Siman, R., Lin, Y., Malthankar‐Phatak, G. H., & Dong, Y. (2013) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0000000000000006 · Cited by 27
Zhu, S., Abounit, S., Korth, C., & Zurzolo, C. (2017) · Open Biology · doi:10.1098/rsob.160328 · Cited by 26
Cellular Biology of Tau Diversity and Pathogenic Conformers
Kang, S., Eskandari‐Sedighi, G., Hromádková, L., Safar, J., & Westaway, D. A. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.590199 · Cited by 29
Zhao, K., Lane, G. I., Wang, L., Price, V. J., Kim, M. H., Cornwell, G. C., Fulenchek, S., Breen, G. A. M., Goux, W. J., & D’Mello, S. R. (2010) · Journal of Neuroscience Research · doi:10.1002/jnr.22485 · Cited by 27
Kang, S., Ha, S., Park, H., Nam, E., Suh, W. H., Suh, Y., & Chang, K. (2018) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2018.00273 · Cited by 27
Ueno, H., Suemitsu, S., Murakami, S., Kitamura, N., Wani, K., Matsumoto, Y., Okamoto, M., & Ishihara, T. (2018) · IBRO Reports · doi:10.1016/j.ibror.2018.11.006 · Cited by 26
Meyer, V., Holden, M. R., Weismiller, H. A., Eaton, G. R., Eaton, S. S., & Margittai, M. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.715557 · Cited by 26
Prelysosomal Compartments in the Unconventional Secretion of Amyloidogenic Seeds
Madsen, H. B., & Vilhardt, F. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18010227 · Cited by 26
Song, L., Oseid, D. E., Wells, E. A., Coaston, T. N., & Robinson, A. S. (2022) · Journal of Molecular Neuroscience · doi:10.1007/s12031-021-01943-2 · Cited by 28
GPI anchoring facilitates propagation and spread of misfolded Sup35 aggregates in mammalian cells
Speare, J. O., Offerdahl, D. K., Hasenkrug, A. M., Carmody, A., & Baron, G. S. (2010) · The EMBO Journal · doi:10.1038/emboj.2009.392 · Cited by 27
Visualization of prion-like transfer in Huntington's disease models
Jansen, A. H. P., Batenburg, K. L., Pecho‐Vrieseling, E., & Reits, E. A. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.12.015 · Cited by 26
Let’s make microglia great again in neurodegenerative disorders
Guillot‐Sestier, M., & Town, T. (2017) · Journal of Neural Transmission · doi:10.1007/s00702-017-1792-x · Cited by 26
Prion-like properties of disease-relevant proteins in amyotrophic lateral sclerosis
Bräuer, S., Zimyanin, V. L., & Hermann, A. (2018) · Journal of Neural Transmission · doi:10.1007/s00702-018-1851-y · Cited by 29
Nakajima, M., Miyajima, M., Akiba, C., Ogino, I., Kawamura, K., Sugano, H., Hara, T., Tange, Y., Fusegi, K., Karagiozov, K. L., et al. (2018) · Operative Neurosurgery · doi:10.1093/ons/opy044 · Cited by 27
Chambraud, B., Daguinot, C., Guillemeau, K., Genet, M., Dounane, O., Méduri, G., Poüs, C., Baulieu, E. E., & Giustiniani, J. (2021) · Autophagy · doi:10.1080/15548627.2021.1875611 · Cited by 27
Impairment of entorhinal cortex network activity in Alzheimer’s disease
Karimani, F., Taei, A. A., Abolghasemi-Dehaghani, M.-R., Safari, M.-S., & Dargahi, L. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1402573 · Cited by 27
Amyloid-β oligomers increase the binding and internalization of tau oligomers in human synapses
Kadamangudi, S., Marcatti, M., Zhang, W.-R., Fracassi, A., Kayed, R., Limon, A., & Taglialatela, G. (2024) · Acta Neuropathologica · doi:10.1007/s00401-024-02839-2 · Cited by 25
Infectivity versus Seeding in Neurodegenerative Diseases Sharing a Prion-Like Mechanism
Fernández‐Borges, N., Eraña, H., Elezgarai, S. R., Harrathi, C., Gayosso, M., & Castilla, J. (2013) · International Journal of Cell Biology · doi:10.1155/2013/583498 · Cited by 26
Eraña, H., Venegas, V., Charco, J. M., & Castilla, J. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.08.166 · Cited by 26
Secretion of full-length tau or tau fragments in a cell culture model
Pérez, M., Cuadros, R., Hernández, F., & Ávila, J. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.09.026 · Cited by 27
Influence of traumatic brain injury on extracellular tau elimination at the blood–brain barrier
Eisenbaum, M., Pearson, A., Gratkowski, A., Mouzon, B., MULLAN, M. J., Crawford, F., Ojo, J. O., & Bachmeier, C. J. (2021) · Fluids and Barriers of the CNS · doi:10.1186/s12987-021-00283-y · Cited by 26
Kellett, K. A. B., & Hooper, N. M. (2015) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-94-017-7197-9_17 · Cited by 25
Significance and limitation of the pathological classification of TDP ‐43 proteinopathy
Arai, T. (2014) · Neuropathology · doi:10.1111/neup.12138 · Cited by 29
Furukawa, Y., & Nukina, N. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.04.011 · Cited by 25
Sequence-dependent Internalization of Aggregating Peptides
Couceiro, J. R., Gallardo, R. U., Smet, F. D., Baets, G. D., Baatsen, P., Annaert, W. G., Roose, K., Saelens, X., Schymkowitz, J. W. H., & Rousseau, F. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.586636 · Cited by 27
The Involvement of Cholinergic Neurons in the Spreading of Tau Pathology
Simón, D., Hernández, F., & Avila, J. (2013) · Frontiers in Neurology · doi:10.3389/fneur.2013.00074 · Cited by 25
Calcium flux and endothelial dysfunction during acute lung injury: a STIMulating target for therapy
Seeley, E. J., Rosenberg, P. B., & Matthay, M. A. (2013) · Journal of Clinical Investigation · doi:10.1172/jci68093 · Cited by 27
Absence of a Role for Phosphorylation in the Tau Pathology of Alzheimer’s Disease
Lai, R. Y. K., Harrington, C. R., & Wischik, C. M. (2016) · Biomolecules · doi:10.3390/biom6020019 · Cited by 24
Morrow, K. A., Frank, D. W., Balczon, R., & Stevens, T. (2016) · Handbook of experimental pharmacology · doi:10.1007/164_2016_5003 · Cited by 25
“Tau immunotherapy: Hopes and hindrances”
Shahpasand, K., Shamloo, A. S., Nabavi, S. M., Lu, K. P., & Zhou, X. Z. (2017) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2017.1393594 · Cited by 25
Modeling neurodegeneration in chronic traumatic encephalopathy using gradient damage models
Noël, L., & Ellen Kuhl, A. (2019) · Computational Mechanics · doi:10.1007/s00466-019-01717-z · Cited by 22
Protein aggregates stimulate macropinocytosis facilitating their propagation
Yerbury, J. J. (2016) · Prion · doi:10.1080/19336896.2016.1141860 · Cited by 26
Structural and functional damage to neuronal nuclei caused by extracellular tau oligomers
Sun, X., Eastman, G., Shi, Y., Saibaba, S., Oliveira, A. K., Lukens, J. R., Norambuena, A., Thompson, J. A., Purdy, M. D., Dryden, K. A., et al. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13535 · Cited by 24
Braidy, N., Gai, W.-P., Xu, Y. H., Sachdev, P. S., Guillemin, G. J., Jiang, X., Ballard, J. W. O., Horan, M. P., Fang, Z. M., Chong, B. H., et al. (2013) · Neurotoxicity Research · doi:10.1007/s12640-013-9420-5 · Cited by 24
Cerebrospinal fluid from Alzheimer’s disease patients promotes tau aggregation in transgenic mice
Skachokova, Z. K., Martinisi, A., Flach, M., Sprenger, F., Naegelin, Y., Steiner-Monard, V., Sollberger, M. A., Monsch, A. U., Goedert, M., Tolnay, M., et al. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0725-3 · Cited by 27
Tau Interacting Proteins: Gaining Insight into the Roles of Tau in Health and Disease
Stancu, I., Ferraiolo, M., Terwel, D., & Dewachter, I. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-32-9358-8_13 · Cited by 23
Selective neuronal vulnerability in Alzheimer’s disease
Wang, Z.-T., Zhang, C. M., Wang, Y., Dong, Q., Tan, L., & Yu, J. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101114 · Cited by 24
Poursaei, E., Abolghasemi, M., Bornehdeli, S., Shanehbandi, D., Asadi, M., Sadeghzadeh, M., Rahmanpour, D., & Sadeh, R. N. (2021) · Psychiatric Genetics · doi:10.1097/ypg.0000000000000303 · Cited by 24
DnaJC7 specifically regulates tau seeding
Perez, V. A., Sanders, D. W., Mendoza‐Oliva, A., Stopschinski, B. E., Mullapudi, V., White, C. L., Joachimiak, Ł. A., & Diamond, M. I. (2023) · eLife · doi:10.7554/elife.86936 · Cited by 24
Self-citationDeath or secretion? The demise of a plausible assumption about CSF-tau in Alzheimer Disease?
Hall, G. F., & Saman, S. (2012) · Communicative & Integrative Biology · doi:10.4161/cib.21437 · Cited by 26
Constrained instruments and their application to Mendelian randomization with pleiotropy
Jiang, L., Oualkacha, K., Didelez, V., Ciampi, A., Rosa‐Neto, P., Benedet, A. L., Mathotaarachchi, S., Richards, J. B., Greenwood, C. M. T., & Initiative, A. F. T. A. D. N. (2019) · Genetic Epidemiology · doi:10.1002/gepi.22184 · Cited by 23
Potential common pathogenesis of several neurodegenerative diseases
Fan, T., Peng, J., Liang, H., Chen, W., Wang, J., & Xu, R. (2025) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-01054 · Cited by 29
A High-Throughput Screening Assay for Determining Cellular Levels of Total Tau Protein
Dehdashti, S., Zheng, W., Gever, J. R., Wilhelm, R. S., Nguyễn, Ð.-T., Sittampalam, G. S., McKew, J. C., Austin, C. P., & Prusiner, S. B. (2013) · Current Alzheimer Research · doi:10.2174/15672050113109990143 · Cited by 23
Neurodegenerative lesions: Seeding and spreading
Duyckaerts, C. J. (2013) · Revue Neurologique · doi:10.1016/j.neurol.2013.07.018 · Cited by 24
Intraneuronal Tau Misfolding Induced by Extracellular Amyloid-β Oligomers
Rudenko, L. K., Wallrabe, H. K., Periasamy, A., Siller, K. H., Švindrych, Z., Seward, M. E., Best, M. N., & Bloom, G. S. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190226 · Cited by 24
Pollack, S. J., Trigg, J. E., Khanom, T., Biasetti, L., Marshall, K. E., Al‐Hilaly, Y. K., Rickard, J. E., Harrington, C. R., Wischik, C. M., & Serpell, L. C. (2020) · Journal of Molecular Biology · doi:10.1016/j.jmb.2020.05.027 · Cited by 22
Repetitive Head Trauma Induces Chronic Traumatic Encephalopathy by Multiple Mechanisms
Cherry, J. D., Babcock, K. J., & Goldstein, L. E. (2020) · Seminars in Neurology · doi:10.1055/s-0040-1713620 · Cited by 24
Kerwin, J., Yücesoy, A., Vidhate, S., Dávila-Montero, B. M., Orman, J. L. V., Pence, T. J., Tartis, M., Mejía-Álvarez, R., & Willis, A. M. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.832370 · Cited by 25
Shevtsova, E. F., Angelova, P. R., Stelmashchuk, O. A., Esteras, N., Васильева, Н. А., Maltsev, A. V., Shevtsov, P. N., Shaposhnikov, A. V., Фисенко, В. П., Бачурин, С. О., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-16817-9 · Cited by 26
Park, S. M., & Kim, K. S. (2013) · Prion · doi:10.4161/pri.22850 · Cited by 23
Chronic Traumatic Encephalopathy: The cellular sequela to repetitive brain injury
Vile, A., & Atkinson, L. (2017) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2017.03.035 · Cited by 24
Apetri, A. C., Crespo, R., Juraszek, J., Pascual, G., Janson, R., Zhu, X., Zhang, H., Keogh, E. A., Holland, T., Wadia, J., et al. (2018) · Acta Neuropathologica Communications · doi:10.1186/s40478-018-0543-z · Cited by 22
Tanaka, Y., Yamada, K., Satake, K., Nishida, I., Heuberger, M., Kuwahara, T., & Iwatsubo, T. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.01258 · Cited by 22
Prion-like strain effects in tauopathies
Han, Z. Z., Kang, S., Arce, L., & Westaway, D. A. (2022) · Cell and Tissue Research · doi:10.1007/s00441-022-03620-1 · Cited by 24
Metadata
- Authors
- Frost, B., Jacks, R. L., & Diamond, M. I.
- Affiliations
- University of California, San Francisco (US)
- Corresponding author
- Diamond, Marc I.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2009-05
- Volume
- 284
- Issue
- 19
- Pages
- 12845-12852
- ISSN
- 0021-9258 (ISSN-L)
- PMC
- PMC2676015
- OpenAlex
- W1989208474
- Cited by
- 1,252
- References
- 32
- Citations by year
- 2026: 34 · 2025: 71 · 2024: 76 · 2023: 78 · 2022: 72 · 2021: 96 · 2020: 97 · 2019: 70 · 2018: 67 · 2017: 76 · 2016: 67 · 2015: 83 · 2014: 78 · 2013: 89 · 2012: 81
- FWCI
- 43.07
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Muscular Dystrophy Association
- National Institutes of Health
- University of California, San Francisco
- National Institute of Neurological Disorders and Stroke (R01NS050284, R01 NS50284-03)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Prion Diseases and Protein Misfolding
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- tauopathy, prion-like propagation, fluid-phase endocytosis, Alzheimer's disease, frontotemporal dementia
- MeSH terms
- Animals, Animals, Newborn, Cell Line, Dextrans, Extracellular Space, Flow Cytometry, Fluorescent Antibody Technique, Humans, Kidney, Luminescent Proteins, Neurons, Stem Cells, Blotting, Western, tau Proteins, Protein Folding, Microscopy, Atomic Force, Coculture Techniques, Intracellular Space, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
